Clarification on the News of the Artificial Strain of Hepatitis B

King Khalid University, Media Center
Registered with the National Center for Biotechnology Information

We recently published news about the discovery of a research team at the University of a vaccine for Hepatitis B and cholera, which aims to achieve prevention of the disease and prevent the occurrence of infection with hepatitis B, which may lead to liver cancer.

We would like to clarify that the artificial strain of hepatitis B and subtypes B of the cholera toxin has been registered in the Gene Bank within the BioProjects No. PRJNA386722.

This can be found through the link


Currently, it is still at the level of laboratory production (Bench Top). The research team seeks to develop research in this area in the coming period, God willing, according to international standards and precise scientific controls and research.